NIH defies FOIA, Moderna vaxx royalties paid to government will remain state secret
By News Editors // May 03, 2024

COVID Propaganda Roundup: The latest updates on the “new normal” – chronicling the lies, distortions, and abuses by the ruling class.

(Article by Ben Bartee republished from ArmageddonProse.Substack.com)

NIH defies FOIA, vaxx royalty data remains shrouded in secrecy

“The very word ‘secrecy’ is repugnant in a free and open society; and we are as a people inherently and historically opposed to secret societies, to secret oaths and to secret proceedings...

We are opposed around the world by a monolithic and ruthless conspiracy that relies primarily on covert means for expanding its sphere of influence–on infiltration instead of invasion, on subversion instead of elections, on intimidation instead of free choice, on guerrillas by night instead of armies by day. It is a system which has conscripted vast human and material resources into the building of a tightly knit, highly efficient machine that combines military, diplomatic, intelligence, economic, scientific and political operations. Its preparations are concealed, not published. Its mistakes are buried, not headlined. Its dissenters are silenced, not praised. No expenditure is questioned, no rumor is printed, no secret is revealed.”

-John F. Kennedy (assassinated)

Via The Epoch Times (emphasis added):

The U.S. National Institutes of Health (NIH) is refusing to release additional information about an agreement it reached over a COVID-19 vaccine that has earned it at least $400 million.

The NIH declined to provide any materials in response to a Freedom of Information Act request from The Epoch Times.

‘The NIH withholds the entirety of the records as they are protected from release,’ Gorka Garcia-Malene, an NIH officer, told The Epoch Times in a letter.

She cited an exemption outlined in the act that allows government agencies to partially or fully withhold information.

‘In this case, exemption 3 incorporates 35 U.S.C. 209 (f), which reads in relevant part, ‘No Federal agency shall grant any license under a patent or patent application on a federally owned invention unless the person requesting the license has supplied the agency with a plan for development or marketing of the invention, except that any such plan shall be treated by the Federal agency as commercial and financial information obtained from a person and privileged and confidential and not subject to disclosure under section 552 of title 5,’’ Ms. Garcia-Malene wrote.

Exemption 4 protects from disclosure trade secrets and commercial or financial information that is privileged and confidential,’ she added.”

What is left to say? It’s been three years and a billion tears, to paraphrase Social Distortion, the $400 million Moderna kickback has been public knowledge for over a year, and no amount of screaming into the ether nor bureaucratic hoop-jumping apparently has any effect whatsoever on the political leadership class in our so-called democracy.

Read more at: ArmageddonProse.Substack.com



Take Action:
Support NewsTarget by linking to this article from your website.
Permalink to this article:
Copy
Embed article link:
Copy
Reprinting this article:
Non-commercial use is permitted with credit to NewsTarget.com (including a clickable link).
Please contact us for more information.
Free Email Alerts
Get independent news alerts on natural cures, food lab tests, cannabis medicine, science, robotics, drones, privacy and more.

NewsTarget.com © 2022 All Rights Reserved. All content posted on this site is commentary or opinion and is protected under Free Speech. NewsTarget.com is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. NewsTarget.com assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published on this site. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners.

This site uses cookies
News Target uses cookies to improve your experience on our site. By using this site, you agree to our privacy policy.
Learn More
Close
Get 100% real, uncensored news delivered straight to your inbox
You can unsubscribe at any time. Your email privacy is completely protected.